Maria Hedmer
51 – 60 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
SURFACE MONITORING OF ANTINEOPLASTIC DRUGS IN SWEDISH HOSPITALS AND HYGIENIC GUIDANCE VALUES
2011) Airmon 7th International Synposium on Modern Principles of Air Monitoring and Biomonitoring(
- Contribution to conference › Abstract
-
Mark
Risk assessment for Carbon nanotubes
2011) Ramazzini Days(
- Contribution to conference › Abstract
-
Mark
Soot Particle-AMS for time and composition resolved detection of engineered metal particles
2011) Annual Symposium of the Nordic Society for Aerosol Research (NOSA), 2011(
- Contribution to conference › Abstract
- 2008
-
Mark
Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients
(
- Contribution to journal › Article
-
Mark
Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.
(
- Contribution to journal › Article
-
Mark
Hygiene In High–Tech Industry – Don´t Forget The Traditional Industry
2008) International Occupational Hygiene Association 7th International scientific conference(
- Contribution to conference › Abstract
- 2006
-
Mark
Monitoring of occupational exposure to antineoplastic drugs
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients
2006) 36th Annual Metting of the Environmental Mutagen Scociety(
- Contribution to conference › Abstract
-
Mark
Kartläggning av exponering för cytostatika för sjukhuspersonal: effekt i form av nya rutiner och minskad exponering
2006) Hälsofrämjande sjukhus, 11:e nationella konferensen(
- Contribution to conference › Abstract
- 2005
-
Mark
Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in sweden.
(
- Contribution to journal › Article